Francisco Javier Oliver

12PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersMolecular targetsMechanobiologyHaematological tumoursPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 10, 2026
PARP inhibition modulates mitochondrial morphology and metabolism under hypoxic stress in cancer cells.

|Dec 30, 2025
Targeting MARylation and DePARylation in Cancer Therapy: New Promising Therapeutic Opportunities.

Vanesa Cabeza-Fernández, Francisco Javier Ríos-Sola, David Martín-Oliva

|Feb 25, 2025
Chromosomal 3p loss and 8q gain drive vasculogenic mimicry via HIF-2α and VE-cadherin activation in uveal melanoma.

Daniel Delgado-Bellido, Antonio Chacon-Barrado, Joaquin Olmedo-Pelayo

|Feb 05, 2025
Regulation of ER stress-induced apoptotic and inflammatory responses via YAP/TAZ-mediated control of the TRAIL-R2/DR5 signaling pathway.

Y El Yousfi, F J Fernández-Farrán, F J Oliver

|Jun 10, 2023
VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation.

Daniel Delgado-Bellido, F J Oliver, María Victoria Vargas Padilla

|Feb 16, 2023
VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry.

Daniel Delgado-Bellido, Esteban Zamudio-Martínez, Mónica Fernández-Cortés

Pageof 2

Frequent Collaborators

5 joint publications

Daniel Delgado-Bellido

3 joint publications

Enrique de Álava

2 joint publications

Vanesa Cabeza-Fernández

2 joint publications

José Manuel Rodríguez-Vargas